Detalhe da pesquisa
1.
Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan.
Future Oncol
; 18(8): 937-951, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35043687
2.
Impact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five European countries and Japan.
BMC Urol
; 22(1): 33, 2022 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35277153
3.
Systematic Literature Review of the Epidemiology of Advanced Prostate Cancer and Associated Homologous Recombination Repair Gene Alterations.
J Urol
; 205(4): 977-986, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332152
4.
Real-world genetic testing patterns in metastatic castration-resistant prostate cancer.
Future Oncol
; 17(22): 2907-2921, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33906368
5.
Patient preferences for treatment of metastatic melanoma.
Future Oncol
; 15(11): 1255-1268, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30694080
6.
Stage III melanoma incidence and impact of transitioning to the 8th AJCC staging system: a US population-based study.
Future Oncol
; 15(4): 359-370, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30317881
7.
Targeted agents or immuno-oncology therapies as first-line therapy for BRAF-mutated metastatic melanoma: a real-world study.
Future Oncol
; 15(25): 2933-2942, 2019 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30799646
8.
Healthcare utilization and costs for patients initiating Dabigatran or Warfarin.
Health Qual Life Outcomes
; 15(1): 128, 2017 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28637460
9.
Patterns of care among patients receiving sequential targeted therapies for advanced renal cell carcinoma: A retrospective chart review in the USA.
Int J Urol
; 24(4): 272-278, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28253548
10.
Real-World Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Across Europe (France, Germany, Italy, Spain, and the United Kingdom) and Japan.
Adv Ther
; 39(5): 2236-2255, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316501
11.
Hemorrhagic and thrombotic events associated with generic substitution of warfarin in patients with atrial fibrillation: a retrospective analysis.
Ann Pharmacother
; 45(6): 701-12, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21666081
12.
Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors.
Adv Ther
; 38(8): 4520-4540, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34282527
13.
Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US Study.
Clin Genitourin Cancer
; 19(6): 480-490, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34373223
14.
Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Target Oncol
; 16(5): 613-623, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34478046
15.
Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive.
Melanoma Res
; 29(3): 301-310, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30247203
16.
Budget Impact of Dabrafenib and Trametinib in Combination as Adjuvant Treatment of BRAF V600E/K Mutation-Positive Melanoma from a U.S. Commercial Payer Perspective.
J Manag Care Spec Pharm
; 25(11): 1227-1237, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31663466
17.
Cost-effectiveness of dabrafenib and trametinib in combination as adjuvant treatment of BRAF V600E/K mutation-positive melanoma from a US healthcare payer perspective.
J Med Econ
; 22(12): 1243-1252, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31223037
18.
Association between cardiometabolic risk factors and body mass index based on diagnosis and treatment codes in an electronic medical record database.
J Manag Care Pharm
; 14(8): 756-67, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18983205
19.
The Additional Costs per Month of Progression-Free Survival and Overall Survival: An Economic Model Comparing Everolimus with Cabozantinib, Nivolumab, and Axitinib for Second-Line Treatment of Metastatic Renal Cell Carcinoma.
J Manag Care Spec Pharm
; 24(4): 335-343, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29578848
20.
Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly.
Am Health Drug Benefits
; 11(7): 334-343, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30647822